临床荟萃
• 专题 • 上一篇 下一篇
出版日期:
发布日期:
通讯作者:
作者简介:
Online:
Published:
Contact:
摘要： 药物性肝损伤(DILI)是引发肝病的重要原因之一。随着药物种类越来越多，应用日益广泛，DILI的发生率逐年上升，已成为一个严重的公共卫生问题。因此，了解药物性肝损伤的病因、发病机制、临床特征、诊断、治疗等尤为重要，本文就其中的一些研究进展做一简要综述。
关键词: 药物性肝损伤, 生物学标记, 疾病特征
Abstract: Drug induced liver injury (DILI) is one of the important causes of liver disease. With more and more types of drugs are used widely， the incidence of DILI raiseds year by year， which has become a serious public health problem. Therefore， it is very important to understand the etiology， pathogenesis， clinical features， diagnosis and treatment of DILI. This paper makes a brief summary of some research progress.
Key words: druginduced liver injury；biological markers, disease attributes
任美欣，孟庆华. 药物性肝损伤[J]. 临床荟萃, doi: 10.3969/j.issn.1004-583X.2016.07.005.
Ren Meixin，Meng Qinghua. Drug induced liver injury[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2016.07.005.
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2016.07.005
https://huicui.hebmu.edu.cn/CN/Y2016/V31/I7/713
